The goal was to identify stage- and MYCN amplification-specific splicing patterns in comparison to whole gene expression changes for the understanding of cancer biology and discovery of biomarkers or therapeutic targets in neuroblastoma. The gene discussed is MYCN; the disease is neuroblastoma.